Model for end-stage liver disease (MELD) exception for uncommon hepatic tumors
โ Scribed by Jeffrey Punch; Robert G. Gish
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 57 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20970
No coin nor oath required. For personal study only.
โฆ Synopsis
Liver transplantation has been performed for a wide variety of rare hepatic tumors. The anecdotal nature of this experience makes evidence-based decisions regarding suitability for transplantation very challenging. The largest reports of transplantation for tumors other than hepatocellular carcinoma and cholangiocarcinoma have been for neuroendocrine tumors. Hepatic metastases are present in approximately 75% of patients at the time a neuroendocrine tumor is diagnosed, and cure by liver transplantation (LT) is rare.
๐ SIMILAR VOLUMES
Polycystic liver disease (PLD) is commonly associated with polycystic kidney disease, but is unaccompanied by renal cysts in 10% of cases. Symptomatic PLD is mainly limited to adults and rarely, if ever, presents in childhood. There is currently no effective medical therapy for PLD. Most patients wh
Cystic fibrosis (CF) is a multisystem disease caused by mutations in a single gene (cystic fibrosis transmembrane conductance regulator) and is the most frequent potentially fatal inherited condition in whites, occurring in 1 in 2,000 births. Progressive pulmonary disease is the major contributor to